NephroGenex To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference
NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Chief Executive Officer Pierre Legault will present a corporate overview of the Company and meet with investors at the 17th Annual BIO CEO & Investor Conference in New York City.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.